Bcl11b, a Novel GATA3-interacting Protein, Suppresses Th1 While Limiting Th2 Cell Differentiation

Difeng Fang,Kairong Cui,Gangqing Hu,Rama Krishna Gurram,Chao Zhong,Andrew J. Oler,Ryoji Yagi,Ming Zhao,Suveena Sharma,Pentao Liu,Bing Sun,Keji Zhao,Jinfang Zhu
DOI: https://doi.org/10.1084/jem.20171127
2018-01-01
The Journal of Experimental Medicine
Abstract:GATA-binding protein 3 (GATA3) acts as the master transcription factor for type 2 T helper (Th2) cell differentiation and function. However, it is still elusive how GATA3 function is precisely regulated in Th2 cells. Here, we show that the transcription factor B cell lymphoma 11b (Bcl11b), a previously unknown component of GATA3 transcriptional complex, is involved in GATA3-mediated gene regulation. Bcl11b binds to GATA3 through protein–protein interaction, and they colocalize at many important cis-regulatory elements in Th2 cells. The expression of type 2 cytokines, including IL-4, IL-5, and IL-13, is up-regulated in Bcl11b-deficient Th2 cells both in vitro and in vivo; such up-regulation is completely GATA3 dependent. Genome-wide analyses of Bcl11b- and GATA3-regulated genes (from RNA sequencing), cobinding patterns (from chromatin immunoprecipitation sequencing), and Bcl11b-modulated epigenetic modification and gene accessibility suggest that GATA3/Bcl11b complex is involved in limiting Th2 gene expression, as well as in inhibiting non-Th2 gene expression. Thus, Bcl11b controls both GATA3-mediated gene activation and repression in Th2 cells.
What problem does this paper attempt to address?